Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

A critical role for estrogen signaling in penis development.

Govers LC, Phillips TR, Mattiske DM, Rashoo N, Black JR, Sinclair A, Baskin LS, Risbridger GP, Pask AJ.

FASEB J. 2019 Jun 21:fj201802586RR. doi: 10.1096/fj.201802586RR. [Epub ahead of print]

PMID:
31225966
2.

Risk factors for urethral gonorrhoea infection among heterosexual males in Melbourne, Australia: 2007-17.

Phillips TR, Fairley CK, Chen MY, Bradshaw CS, Chow EPF.

Sex Health. 2019 Jun 17. doi: 10.1071/SH19027. [Epub ahead of print]

PMID:
31203836
3.

Thiodipeptides targeting the intestinal oligopeptide transporter as a general approach to improving oral drug delivery.

Foley DW, Pathak RB, Phillips TR, Wilson GL, Bailey PD, Pieri M, Senan A, Meredith D.

Eur J Med Chem. 2018 Aug 5;156:180-189. doi: 10.1016/j.ejmech.2018.06.064. Epub 2018 Jun 30.

4.

Development and Validation of MMPI-2-RF Scales for Indexing Triarchic Psychopathy Constructs.

Sellbom M, Drislane LE, Johnson AK, Goodwin BE, Phillips TR, Patrick CJ.

Assessment. 2016 Oct;23(5):527-43. doi: 10.1177/1073191115590853. Epub 2015 Jul 1.

PMID:
26139828
5.

A Comprehensive Atlas of the Adult Mouse Penis.

Phillips TR, Wright DK, Gradie PE, Johnston LA, Pask AJ.

Sex Dev. 2015;9(3):162-72. doi: 10.1159/000431010. Epub 2015 Jun 19.

6.

Gradient compression garments protect against orthostatic intolerance during recovery from bed rest.

Stenger MB, Lee SM, Ribeiro LC, Phillips TR, Ploutz-Snyder RJ, Willig MC, Westby CM, Platts SH.

Eur J Appl Physiol. 2014 Mar;114(3):597-608. doi: 10.1007/s00421-013-2787-4. Epub 2013 Dec 14.

PMID:
24337701
7.

Further development and construct validation of MMPI-2-RF indices of global psychopathy, fearless-dominance, and impulsive-antisociality in a sample of incarcerated women.

Phillips TR, Sellbom M, Ben-Porath YS, Patrick CJ.

Law Hum Behav. 2014 Feb;38(1):34-46. doi: 10.1037/lhb0000040. Epub 2013 Jul 15.

PMID:
23855322
8.

Abdomen-high elastic gradient compression garments during post-spaceflight stand tests.

Stenger MB, Lee SM, Westby CM, Ribeiro LC, Phillips TR, Martin DS, Platts SH.

Aviat Space Environ Med. 2013 May;84(5):459-66.

PMID:
23713210
9.

An examination of the triarchic conceptualization of psychopathy in incarcerated and nonincarcerated samples.

Sellbom M, Phillips TR.

J Abnorm Psychol. 2013 Feb;122(1):208-214. doi: 10.1037/a0029306. Epub 2012 Aug 6.

PMID:
22867118
10.

Synthesis and evaluation of a novel series of indoloisoquinolines as small molecule anti-malarial leads.

Horrocks P, Fallon S, Denman L, Devine O, Duffy LJ, Harper A, Meredith EL, Hasenkamp S, Sidaway A, Monnery D, Phillips TR, Allin SM.

Bioorg Med Chem Lett. 2012 Feb 15;22(4):1770-3. doi: 10.1016/j.bmcl.2011.12.071. Epub 2011 Dec 21.

PMID:
22264480
11.

Screening assay for oxidative stress in a feline astrocyte cell line, G355-5.

Testa MP, Alvarado O, Wournell A, Lee J, Guilford FT, Henriksen SH, Phillips TR.

J Vis Exp. 2011 Jul 13;(53):e2841. doi: 10.3791/2841.

12.

Artificial gravity training reduces bed rest-induced cardiovascular deconditioning.

Stenger MB, Evans JM, Knapp CF, Lee SM, Phillips TR, Perez SA, Moore AD Jr, Paloski WH, Platts SH.

Eur J Appl Physiol. 2012 Feb;112(2):605-16. doi: 10.1007/s00421-011-2005-1. Epub 2011 May 29.

PMID:
21626041
13.

Fragment-based drug discovery applied to Hsp90. Discovery of two lead series with high ligand efficiency.

Murray CW, Carr MG, Callaghan O, Chessari G, Congreve M, Cowan S, Coyle JE, Downham R, Figueroa E, Frederickson M, Graham B, McMenamin R, O'Brien MA, Patel S, Phillips TR, Williams G, Woodhead AJ, Woolford AJ.

J Med Chem. 2010 Aug 26;53(16):5942-55. doi: 10.1021/jm100059d.

PMID:
20718493
14.

Methamphetamine and lentivirus interactions: reciprocal enhancement of central nervous system disease.

Huitron-Resendiz S, Henriksen SJ, Barr MC, Testa MP, Crawford E, Parsons LH, Sanchez-Alavez M, Phillips TR.

J Neurovirol. 2010 Jul;16(4):268-78. doi: 10.3109/13550284.2010.497807.

PMID:
20608774
15.

Domain- and nucleotide-specific Rev response element regulation of feline immunodeficiency virus production.

Na H, Huisman W, Ellestad KK, Phillips TR, Power C.

Virology. 2010 Sep 1;404(2):246-60. doi: 10.1016/j.virol.2010.04.009. Epub 2010 Jun 8.

16.

Methamphetamine and AIDS: 1HMRS studies in a feline model of human disease.

Cloak CC, Chang L, Ernst T, Barr MC, Huitron-Resendiz S, Sanchez-Alavez M, Phillips TR, Henriksen S.

J Neuroimmunol. 2004 Feb;147(1-2):16-20.

PMID:
14741420
17.

Escalating morphine exposures followed by withdrawal in feline immunodeficiency virus-infected cats: a model for HIV infection in chronic opiate abusers.

Barr MC, Huitron-Resendiz S, Sanchez-Alavez M, Henriksen SJ, Phillips TR.

Drug Alcohol Depend. 2003 Nov 24;72(2):141-9.

PMID:
14636969
18.

A malaria vaccine candidate based on a hepatitis B virus core platform.

Sällberg M, Hughes J, Jones J, Phillips TR, Milich DR.

Intervirology. 2002;45(4-6):350-61.

PMID:
12602355
19.

Effects of 1,8-diaminooctane on the FIV Rev regulatory system.

Hart RA, Billaud JN, Choi SJ, Phillips TR.

Virology. 2002 Dec 5;304(1):97-104.

20.

Inhibition of feline immunodeficiency virus (FIV) replication by DNA binding polyamides.

Sharma SK, Billaud JN, Tandon M, Billet O, Choi S, Kopka ML, Phillips TR, Lown JW.

Bioorg Med Chem Lett. 2002 Aug 5;12(15):2007-10.

PMID:
12113829
21.

FIV and neuroAIDS.

Fox HS, Phillips TR.

J Neurovirol. 2002 Jun;8(3):155-7. Review. No abstract available.

PMID:
12053270
22.

Conversion of poorly immunogenic malaria repeat sequences into a highly immunogenic vaccine candidate.

Milich DR, Hughes J, Jones J, Sällberg M, Phillips TR.

Vaccine. 2001 Dec 12;20(5-6):771-88.

PMID:
11738741
23.

Partial characterization and tissue distribution of the feline mu opiate receptor.

Billet O, Billaud JN, Phillips TR.

Drug Alcohol Depend. 2001 Apr 1;62(2):125-9.

PMID:
11245968
24.

Methamphetamine and HIV-1: potential interactions and the use of the FIV/cat model.

Phillips TR, Billaud JN, Henriksen SJ.

J Psychopharmacol. 2000;14(3):244-50. Review.

PMID:
11106303
25.

Borna disease virus persistence causes inhibition of glutamate uptake by feline primary cortical astrocytes.

Billaud JN, Ly C, Phillips TR, de la Torre JC.

J Virol. 2000 Nov;74(22):10438-46.

26.

Effects of multiple acute morphine exposures on feline immunodeficiency virus disease progression.

Barr MC, Billaud JN, Selway DR, Huitron-Resendiz S, Osborn KG, Henriksen SJ, Phillips TR.

J Infect Dis. 2000 Sep;182(3):725-32. Epub 2000 Aug 14.

PMID:
10950765
27.

Exogenous glucocorticoids alter parameters of early feline immunodeficiency virus infection.

Barr MC, Huitron-Resendiz S, Selway DR, Henriksen SJ, Phillips TR.

J Infect Dis. 2000 Feb;181(2):576-86.

PMID:
10669341
28.
29.

Feline immunodeficiency virus envelope protein (FIVgp120) causes electrophysiological alterations in rats.

Prospéro-García O, Huitrón-Resendiz S, Casalman SC, Sánchez-Alavez M, Díaz-Ruiz O, Navarro L, Lerner DL, Phillips TR, Elder JH, Henriksen SJ.

Brain Res. 1999 Jul 31;836(1-2):203-9.

PMID:
10415420
30.

Neurotoxic effects of feline immunodeficiency virus, FIV-PPR.

Gruol DL, Yu N, Parsons KL, Billaud JN, Elder JH, Phillips TR.

J Neurovirol. 1998 Aug;4(4):415-25.

PMID:
9718133
31.

FIV. A lentivirus model for opiate effects on disease.

Billaud JN, Phillips TR.

Adv Exp Med Biol. 1998;437:101-16. Review. No abstract available.

PMID:
9666262
32.
33.

Cortical neuronal cytoskeletal changes associated with FIV infection.

Jacobson S, Henriksen SJ, Prospero-Garcia O, Phillips TR, Elder JH, Young WG, Bloom FE, Fox HS.

J Neurovirol. 1997 Aug;3(4):283-9.

PMID:
9291236
34.
35.

Neurologic dysfunctions caused by a molecular clone of feline immunodeficiency virus, FIV-PPR.

Phillips TR, Prospero-Garcia O, Wheeler DW, Wagaman PC, Lerner DL, Fox HS, Whalen LR, Bloom FE, Elder JH, Henriksen SJ.

J Neurovirol. 1996 Dec;2(6):388-96.

PMID:
8972420
36.

Selection and characterization of a mutant of feline immunodeficiency virus resistant to 2',3'-dideoxycytidine.

Medlin HK, Zhu YQ, Remington KM, Phillips TR, North TW.

Antimicrob Agents Chemother. 1996 Apr;40(4):953-7.

37.

Increased mutation frequency of feline immunodeficiency virus lacking functional deoxyuridine-triphosphatase.

Lerner DL, Wagaman PC, Phillips TR, Prospero-Garcia O, Henriksen SJ, Fox HS, Bloom FE, Elder JH.

Proc Natl Acad Sci U S A. 1995 Aug 1;92(16):7480-4.

38.
39.

Feline immunodeficiency virus as a model for study of lentivirus infection of the central nervous system.

Henriksen SJ, Prospero-Garcia O, Phillips TR, Fox HS, Bloom FE, Elder JH.

Curr Top Microbiol Immunol. 1995;202:167-86. Review.

PMID:
7587362
40.

Sleep patterns are disturbed in cats infected with feline immunodeficiency virus.

Prospéro-García O, Herold N, Phillips TR, Elder JH, Bloom FE, Henriksen SJ.

Proc Natl Acad Sci U S A. 1994 Dec 20;91(26):12947-51.

41.

Intraventricular administration of a FIV-envelope protein induces sleep architecture changes in rats.

Prospéro-García O, Herold N, Waters AK, Phillips TR, Elder JH, Henriksen SJ.

Brain Res. 1994 Oct 3;659(1-2):254-8.

PMID:
7820670
42.

Neurological abnormalities associated with feline immunodeficiency virus infection.

Phillips TR, Prospero-Garcia O, Puaoi DL, Lerner DL, Fox HS, Olmsted RA, Bloom FE, Henriksen SJ, Elder JH.

J Gen Virol. 1994 May;75 ( Pt 5):979-87.

PMID:
8176384
43.
44.

Molecular properties of feline immunodeficiency virus (FIV).

Elder JH, Phillips TR.

Infect Agents Dis. 1993 Dec;2(6):361-74. Review. No abstract available.

PMID:
8012737
45.

Molecular cloning and characterization of deoxyuridine triphosphatase from feline immunodeficiency virus (FIV).

Wagaman PC, Hasselkus-Light CS, Henson M, Lerner DL, Phillips TR, Elder JH.

Virology. 1993 Oct;196(2):451-7.

PMID:
8396797
46.

Identification of proteolytic processing sites within the Gag and Pol polyproteins of feline immunodeficiency virus.

Elder JH, Schnölzer M, Hasselkus-Light CS, Henson M, Lerner DA, Phillips TR, Wagaman PC, Kent SB.

J Virol. 1993 Apr;67(4):1869-76.

47.

Identification of the Rev transactivation and Rev-responsive elements of feline immunodeficiency virus.

Phillips TR, Lamont C, Konings DA, Shacklett BL, Hamson CA, Luciw PA, Elder JH.

J Virol. 1992 Sep;66(9):5464-71.

48.

Distinct subsets of retroviruses encode dUTPase.

Elder JH, Lerner DL, Hasselkus-Light CS, Fontenot DJ, Hunter E, Luciw PA, Montelaro RC, Phillips TR.

J Virol. 1992 Mar;66(3):1791-4.

49.

Characterization of endogenous and recombinant proviral elements of a highly tumorigenic AKR cell line.

Lamont C, Culp P, Talbott RL, Phillips TR, Trauger RJ, Frankel WN, Wilson MC, Coffin JM, Elder JH.

J Virol. 1991 Sep;65(9):4619-28.

50.

Comparison of two host cell range variants of feline immunodeficiency virus.

Phillips TR, Talbott RL, Lamont C, Muir S, Lovelace K, Elder JH.

J Virol. 1990 Oct;64(10):4605-13.

Supplemental Content

Loading ...
Support Center